Please login to the form below

Not currently logged in
Email:
Password:

STEM

This page shows the latest STEM news and features for those working in and with pharma, biotech and healthcare.

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

and chemotherapy drug etoposide, which is used to prepare patients for a haematopoietic stem cell transplant (HSCT), which has improved survival rates in HLH in recent years but still carries a ... In non-responders, Gamifant achieved a 63% response, and

Latest news

More from news
Approximately 16 fully matching, plus 365 partially matching documents found.

Latest Intelligence

  • Brand teams: why are some smarter than others? Brand teams: why are some smarter than others?

    They stem from different philosophies of knowledge. They take as their inputs different kinds of information from different sources.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    Raju Prasad says Bluebird can offer a compelling cost-effectiveness case for its treatment in beta thalassemia and sickle cell cases versus conventional stem cell treatment. ... Conventional stem cell transplants cost anywhere between $500, 000 and $1m,

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    Kathy Niakan is a group leader investigating the mechanisms of lineage specification in human embryos and stem cells, and was the first person ever to be granted a licence to conduct

  • Reaching the new influencers Reaching the new influencers

    Right now, we’re living through healthcare’s age of accelerations - as evidenced by advances in everything from biotechnology and stem cell research to machine learning and the advent (and approvals)

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    Issues from PIP silicone breast implants and metal-on-metal hips stem from very different root causes - the first from deliberate subversion of the regulatory system and the second from unanticipated

More from intelligence
Approximately 1 fully matching, plus 48 partially matching documents found.

Latest appointments

  • Industry appointments Industry appointments

    Rogerio Vivaldi leaves Bioverativ buyout to head up Sigilon. US-based biotech Sigilon aiming to deliver stem cell therapies for diabetes is getting a new leader.

  • Weekly industry appointments Weekly industry appointments

    There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory

  • Simon Doyle joins STEM Simon Doyle joins STEM

    Simon Doyle joins STEM. He takes up a position as vice president, global customer relations development. ... Benchmarking company STEM has appointed Simon Doyle as its new vice president of global customer relations and development.

  • Storm Therapeutics bolsters its team Storm Therapeutics bolsters its team

    As a clinician-scientist at the University of Melbourne, Professor Dawson has experience in epigenetics having spent several years researching epigenetic regulation of leukaemia stem cells.

  • Porterhouse Medical promotes Emma Conran Porterhouse Medical promotes Emma Conran

    Conran has served in medical writing positions at Porterhouse Medical since 2014 and prior to that she was a translational stem cell biology lecturer at King’s College London.

More from appointments
Approximately 3 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 31 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics